Related Experiment Videos

Oculopharyngeal muscular dystrophy in France

M Fardeau1, F M Tomé

  • 1Unité de Recherche de Développement, Pathologie et Régénération Neuromusculaires, INSERM U. 153, Hôpital de la Salpêtrière, Paris, France.

Insights

Oculopharyngeal muscular dystrophy (OPMD) is a progressive genetic disorder. Key findings include characteristic nuclear inclusions in muscle biopsies, serving as a definitive morphological marker for diagnosis.

Area of Science:

  • Neurology
  • Genetics
  • Pathology

Background:

  • Oculopharyngeal muscular dystrophy (OPMD) is a rare, late-onset genetic muscle disease.
  • Characterized by ptosis, dysphagia, and proximal muscle weakness.
  • Previous studies highlight the need for comprehensive data on OPMD clinical and pathological features.

Purpose of the Study:

  • To present clinical, histopathological, ultrastructural, and geographical data of 29 OPMD cases in France.
  • To identify the characteristic morphological markers of OPMD.

Main Methods:

  • Retrospective analysis of clinical data from 29 identified OPMD patients.
  • Histopathological examination of muscle biopsies, including light and electron microscopy.
  • Assessment of geographical distribution and patient demographics.

Main Results:

  • Mean patient age was 53.8 years, with onset symptoms including ptosis, dysphagia, and limb weakness.
  • Muscle biopsies showed atrophic angulated fibers and rimmed vacuoles; necrosis was rare.
  • Characteristic 8.5-nm filament nuclear inclusions were present in all cases (2-5% of nuclei).

Conclusions:

  • Nuclear inclusions are the definitive morphological marker for OPMD.
  • OPMD presents with progressive clinical patterns and distinct histopathological findings.
  • This study provides valuable data on OPMD in a French cohort.

Related Concept Videos